Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Research
Biotech
How Peter Marks plans to prevent '3 billion visits' to FDA
Accelerated approval—controversial, yes—but absolutely necessary for small, pre-revenue biotechs, the FDA’s Peter Marks, M.D., Ph.D., said Wednesday.
Annalee Armstrong
May 8, 2024 11:05am
Regeneron's 'protein factory' gene therapy restores hearing
May 8, 2024 6:00am
mRNA vaccine for glioblastoma targets tumors in humans and dogs
May 7, 2024 5:30am
Novo Nordisk Foundation inks R&D pact for global health issues
May 6, 2024 10:59am
Lilly uses Mounjaro millions to hunt for biotech partners
May 1, 2024 9:26am
Gut enzymes could make universal donor blood possible
Apr 29, 2024 4:32pm